Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer

BackgroundIt is of great significance to find better markers to correctly distinguish between high-risk and low-risk breast cancer patients since the majority of breast cancer cases are at present being overtreated.Methods46 tumours from node-negative breast cancer patients were studied with gene expression microarrays. A t-test was carried out in order to find a set of genes where the expression might predict clinical outcome. Two classifiers were used for evaluation of the gene lists, a correlation-based classifier and a Voting Features Interval (VFI) classifier. We then evaluated the predictive accuracy of this expression signature on tumour sets from two similar studies on lymph-node negative patients. They had both developed gene expression signatures superior to current methods in classifying node-negative breast tumours. These two signatures were also tested on our material.ResultsA list of 51 genes whose expression profiles could predict clinical outcome with high accuracy in our material (96% or 89% accuracy in cross-validation, depending on type of classifier) was developed. When tested on two independent data sets, the expression signature based on the 51 identified genes had good predictive qualities in one of the data sets (74% accuracy), whereas their predictive value on the other data set were poor, presumably due to the fact that only 23 of the 51 genes were found in that material. We also found that previously developed expression signatures could predict clinical outcome well to moderately well in our material (72% and 61%, respectively).ConclusionThe list of 51 genes derived in this study might have potential for clinical utility as a prognostic gene set, and may include candidate genes of potential relevance for clinical outcome in breast cancer. According to the predictions by this expression signature, 30 of the 46 patients may have benefited from different adjuvant treatment than they recieved.Trial registrationThe research on these tumours was approved by the Medical Faculty Research Ethics Committee (Medicinska fakultetens forskningsetikkommitté, Göteborg, Sweden (S164-02)).

[1]  E. Bowman,et al.  Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. , 2004, Human pathology.

[2]  Y. Xiong,et al.  Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function , 2006, Oncogene.

[3]  A. Witteveen,et al.  Converting a breast cancer microarray signature into a high-throughput diagnostic test , 2006, BMC Genomics.

[4]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[5]  S. Sunkara,et al.  A novel human DNA glycosylase that removes oxidative DNA damage and is homologous to Escherichia coli endonuclease VIII. , 2002, DNA repair.

[6]  H. Altay Güvenir,et al.  Classification by Voting Feature Intervals , 1997, ECML.

[7]  Carsten Peterson,et al.  Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles. , 2004, Molecular cancer therapeutics.

[8]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[9]  S. Frank,et al.  GIT2 represses Crk‐ and Rac1‐regulated cell spreading and Cdc42‐mediated focal adhesion turnover , 2006, The EMBO journal.

[10]  B. Olsson,et al.  Chromosomal changes associated with clinical outcome in lymph node-negative breast cancer. , 2007, Cancer genetics and cytogenetics.

[11]  I. Ellis,et al.  A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.

[12]  C. Meijer,et al.  Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. , 2002, Blood.

[13]  Wei Zhang,et al.  Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients , 2007, Breast Cancer Research and Treatment.

[14]  E. Golemis,et al.  A Novel RING Finger Protein, Human Enhancer of Invasion 10, Alters Mitotic Progression through Regulation of Cyclin B Levels , 2003, Molecular and Cellular Biology.

[15]  P. Hall,et al.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Ian H. Witten,et al.  Data mining in bioinformatics using Weka , 2004, Bioinform..

[18]  H. Okamura,et al.  ECA39 is a novel distant metastasis-related biomarker in colorectal cancer. , 2006, World journal of gastroenterology.

[19]  J. Ritz,et al.  SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. , 2006, Blood.

[20]  Thomas Ragg,et al.  The RIN: an RNA integrity number for assigning integrity values to RNA measurements , 2006, BMC Molecular Biology.

[21]  M E Greenberg,et al.  Myc requires distinct E2F activities to induce S phase and apoptosis. , 2001, Molecular cell.

[22]  H. Sugimura,et al.  Inactivating mutations of the human base excision repair gene NEIL1 in gastric cancer. , 2004, Carcinogenesis.

[23]  Christian Pilarsky,et al.  Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer , 2006, Clinical Cancer Research.

[24]  W. Kuo,et al.  Associations between gene expressions in breast cancer and patient survival , 2002, Human Genetics.

[25]  S. Gruvberger,et al.  BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data , 2002, Genome Biology.

[26]  Eytan Domany,et al.  Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.

[27]  M. West,et al.  Genomic prediction of locoregional recurrence after mastectomy in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Alan Mackay,et al.  Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.

[29]  Yusuke Nakamura,et al.  Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers , 2004, Journal of Cancer Research and Clinical Oncology.

[30]  M. West,et al.  Gene expression predictors of breast cancer outcomes , 2003, The Lancet.

[31]  C. Gundy,et al.  Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma , 2005, Clinical Cancer Research.

[32]  E Shelley Hwang,et al.  Identification of a robust gene signature that predicts breast cancer outcome in independent data sets , 2007, BMC Cancer.

[33]  H. Friess,et al.  Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. , 1998, Gene.

[34]  Z. Shao,et al.  Integrated gene expression profile predicts prognosis of breast cancer patients , 2008, Breast Cancer Research and Treatment.

[35]  Dennis B. Troup,et al.  NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..

[36]  Barbara L. Smith,et al.  The effect of tumor size and lymph node status on breast carcinoma lethality , 2003, Cancer.

[37]  Y. Miki,et al.  Postoperative prognosis of node-negative breast cancers predicted by gene-expression profiling on a cDNA microarray of 25,344 genes , 2005, Breast cancer.

[38]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[39]  Gilles Caraux,et al.  PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order , 2005, Bioinform..

[40]  Howard Y. Chang,et al.  Predicting a local recurrence after breast-conserving therapy by gene expression profiling , 2006, Breast Cancer Research.

[41]  J. Cadet,et al.  The fatty acid amide hydrolase 385 A/A (P129T) variant: haplotype analysis of an ancient missense mutation and validation of risk for drug addiction , 2006, Human Genetics.

[42]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[43]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.